Skip to main content
SpringerLink
Log in

Durch Mastzellmediator oder Bradykinin vermittelt?

Cool bleiben beim akuten Angioödem

  • CME Fortbildung
  • Published:
Pneumo News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

© urticaria network e.V.

2

© Angioödemsprechstunde der Charité

3
4

© Angioödemsprechstunde der Charité

5

© Angioödemsprechstunde der Charité

Literatur

  1. Maurer M, Magerl M, Ansotegui I et al. The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update. Allergy. 2018;73(8):1575-96

  2. Ring J, Beyer K, Biedermann T et al. Guideline for acute therapy and management of anaphylaxis: S2 Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Association of German Allergologists (AeDA), the Society of Pediatric Allergy and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Austrian Society for Allergology and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Society for Psychosomatic Medicine (DGPM), the German Working Group of Anaphylaxis Training and Education (AGATE) and the patient organization German Allergy and Asthma Association (DAAB). Allergo J Int. 2014;23(3):96-112

  3. Worm M, Edenharter G, Ruëff F et al. Symptom profile and risk factors of anaphylaxis in Central Europe. Allergy. 2012;67(5):691-8

  4. Zuberbier T, Aberer W, Asero R et al. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018;73(7):1393-1414

  5. Losappio L, Heffler E, Bussolino C et al. Acute urticaria presenting in the emergency room of a general hospital. Eur J Intern Med. 2014;25(2):147-50

  6. Maurer M, Weller K, Bindslev-Jensen C et al. Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report. Allergy. 2011;66(3):317-30

  7. Schoepke N, Młynek A, Weller K et al. Symptomatic dermographism: an inadequately described disease. J Eur Acad Dermatol Venereol. 2015;29(4):708-12

  8. Mathelier-Fusade P, Aïssaoui M, Bakhos D et al. Clinical predictive factors of severity in cold urticaria. Arch Dermatol. 1998;134(1):106-7

  9. Bas M, Greve J, Strassen U et al. Angioedema induced by cardiovascular drugs: new players join old friends. Allergy. 2015;70(10):1196-200

  10. Dewald G, Bork K. Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun. 2006;343(4):1286-9

  11. Bafunno V, Firinu D, D'Apolito M et al. Mutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema. J Allergy Clin Immunol. 2018;141(3):1009-17

  12. Bork K, Wulff K, Steinmüller-Magin L et al. Hereditary angioedema with a mutation in the plasminogen gene. Allergy. 2018;73(2):442-50

  13. Bork K, Wulff K, Rossmann H et al. Hereditary angioedema cosegregating with a novel kininogen 1 gene mutation changing the N-terminal cleavage site of bradykinin. Allergy. 2019;74(12):2479-81

  14. Rasmussen ER, de Freitas PV, Bygum A. Urticaria and Prodromal Symptoms Including Erythema Marginatum in Danish Patients with Hereditary Angioedema. Acta Derm Venereol. 2016;96(3):373-6

  15. Jeon J, Lee YJ, Lee SY. Effect of icatibant on angiotensin-converting enzyme inhibitor-induced angioedema: A meta-analysis of randomized controlled trials. J Clin Pharm Ther. 2019;44(5):685-692

Download references

Author information

Authors and Affiliations

  1. Klinik für Dermatologie, Venerologie und Allergologie, Charité – Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Deutschland

    Thomas Buttgereit &  Markus Magerl

Authors
  1. Thomas Buttgereit
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Markus Magerl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas Buttgereit.

Ethics declarations

Die Autoren erklären, dass sie sich bei der Erstellung des Beitrages von keinen wirtschaftlichen Interessen leiten ließen. T. Buttgereit gibt an, als Referent Honorare für Vorträge von Shire, Takeda, CSL Behring, Genentech, AstraZeneca und Pharming erhalten zu haben. M. Magerl gibt an, als Berater und/oder Referent Honorare von Biocryst, CSL Behring, Kalvista, Shire/Takeda, und Pharming erhalten zu haben.

Der Verlag erklärt, dass die inhaltliche Qualität des Beitrags von zwei unabhängigen Gutachtern geprüft wurde. Werbung in dieser Zeitschriftenausgabe hat keinen Bezug zur CME-Fortbildung. Der Verlag garantiert, dass die CME-Fortbildung sowie die CME-Fragen frei sind von werblichen Aussagen und keinerlei Produktempfehlungen enthalten. Dies gilt insbesondere für Präparate, die zur Therapie des dargestellten Krankheitsbildes geeignet sind.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Buttgereit, T., Magerl, M. Cool bleiben beim akuten Angioödem. Pneumo News 12, 25–33 (2020). https://doi.org/10.1007/s15033-020-1853-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-020-1853-y

Search

Navigation